[Candida albicans prosthetic valve endocarditis. Two cases].
TWO CASES: Candida albicans prosthetic valve endocarditis (PVE) is a rare entity with serious complications. We report two cases of Candida albicans PVE, confirmed by culture of the prosthetic valve. The first patient died twenty days after surgery with cerebral bleeding secondary to multiple mycotic aneurysms, the second patient was still alive eight months following a Saint-Jude aortic valve replacement and prolonged antifungal therapy. The difficulty of diagnosis and management are discussed.
Bouraoui
Hatem
H
Service de Cardiologie, Hôpital Farhat-Hached, 4000 Sousse, Tunisie. hatembouraoui@yahoo.fr
Mahdhaoui
Abdallah
A
Zaaraoui
Jilani
J
Mejdoub
Mohamed
M
Ernez-Hajri
Samia
S
Jeridi
Gouider
G
Ammar
Habib
H
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002176:Candida albicans / Q000302:isolation & purification; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004696:Endocarditis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D017809:Fatal Outcome; D005260:Female; D005437:Flucytosine / Q000627:therapeutic use; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*
D000935:Antifungal Agents; D000666:Amphotericin B; D005437:Flucytosine